Literature DB >> 29039692

Imaging spectrum of immunomodulating, chemotherapeutic and radiation therapy-related intracranial effects.

Christie M Lincoln1, Peter Fata2, Susan Sotardi3, Michael Pohlen1, Tomas Uribe1, Jacqueline A Bello4.   

Abstract

OBJECTIVE: A wide range of treatment-related side effects result in specific neurologic symptoms and signs and neuroimaging features. Even to the most seasoned neuroradiologist, elucidating therapy-related side effects from other common mimics can be challenging. We provide a pictorial survey of some common and uncommon medication-induced and therapy-related neuroimaging manifestations, discuss pathophysiology and common pitfalls in imaging and diagnosis.
METHODS: A case-based review is utilized to depict scenarios on a routine basis in a general radiology or neuroradiology practice such as medication-induced posterior reversible encephalopathy syndrome to the more challenging cases of pseudoprogression and pseudoregression in temozolmide and bevacizumab therapy in gliobastoma treatment protocols.
CONCLUSION: Knowledge of the treatment-induced imaging abnormalities is essential in the accurate interpretation and diagnosis from the most routine to most challenging of clinical situations. We provide a pictorial review for the radiologist to employ in order to be an invaluable provider to our clinical colleagues and patients.

Entities:  

Mesh:

Year:  2017        PMID: 29039692      PMCID: PMC5965791          DOI: 10.1259/bjr.20170553

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  65 in total

Review 1.  Anti-tumor necrosis factor alpha-associated multiple sclerosis.

Authors:  David S Titelbaum; Alexandra Degenhardt; R Philip Kinkel
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

2.  Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings.

Authors:  Jennifer E Fugate; Daniel O Claassen; Harry J Cloft; David F Kallmes; Osman S Kozak; Alejandro A Rabinstein
Journal:  Mayo Clin Proc       Date:  2010-05       Impact factor: 7.616

3.  Detection of microhemorrhage in posterior reversible encephalopathy syndrome using susceptibility-weighted imaging.

Authors:  A M McKinney; B Sarikaya; C Gustafson; C L Truwit
Journal:  AJNR Am J Neuroradiol       Date:  2012-01-12       Impact factor: 3.825

4.  Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro.

Authors:  Yaning Wang; David Fei; Martin Vanderlaan; An Song
Journal:  Angiogenesis       Date:  2005-05-09       Impact factor: 9.596

5.  Acute motor and sensory axonal neuropathy and concomitant encephalopathy during tumor necrosis factor-alpha antagonist therapy.

Authors:  Anthony Faivre; Jérome Franques; Andre Maues De Paula; Mariana Gutierrez; Sandie Bret; Sandrine Aubert; Shahram Attarian; Jean Pouget
Journal:  J Neurol Sci       Date:  2010-02-08       Impact factor: 3.181

6.  Neuropathy resembling CIDP in patients receiving tumor necrosis factor-alpha blockers.

Authors:  C Richez; P Blanco; A Lagueny; T Schaeverbeke; J Dehais
Journal:  Neurology       Date:  2005-04-26       Impact factor: 9.910

7.  A randomized trial of bevacizumab for newly diagnosed glioblastoma.

Authors:  Mark R Gilbert; James J Dignam; Terri S Armstrong; Jeffrey S Wefel; Deborah T Blumenthal; Michael A Vogelbaum; Howard Colman; Arnab Chakravarti; Stephanie Pugh; Minhee Won; Robert Jeraj; Paul D Brown; Kurt A Jaeckle; David Schiff; Volker W Stieber; David G Brachman; Maria Werner-Wasik; Ivo W Tremont-Lukats; Erik P Sulman; Kenneth D Aldape; Walter J Curran; Minesh P Mehta
Journal:  N Engl J Med       Date:  2014-02-20       Impact factor: 91.245

Review 8.  Posterior reversible encephalopathy syndrome.

Authors:  C Lamy; C Oppenheim; J L Mas
Journal:  Handb Clin Neurol       Date:  2014

9.  Ipilimumab-induced hypophysitis: MR imaging findings.

Authors:  K J Carpenter; R D Murtagh; H Lilienfeld; J Weber; F R Murtagh
Journal:  AJNR Am J Neuroradiol       Date:  2009-05-27       Impact factor: 3.825

Review 10.  CNS-immune reconstitution inflammatory syndrome in the setting of HIV infection, part 2: discussion of neuro-immune reconstitution inflammatory syndrome with and without other pathogens.

Authors:  M J D Post; M M Thurnher; D B Clifford; A Nath; R G Gonzalez; R K Gupta; K K Post
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-12       Impact factor: 3.825

View more
  1 in total

1.  Posterior reversible encephalopathy syndrome associated with the use of chemotherapeutic agents: a rare complication after treatment with vinorelbine.

Authors:  Ines Gil; Filipa Serrazina; Miguel Pinto; Miguel Viana-Baptista
Journal:  BMJ Case Rep       Date:  2020-02-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.